Neo, S. Y., Oliveira, M. M. S., Tong, L., Chen, Y., Chen, Z., Cismas, S., Burduli, N., Malmerfelt, A., Teo, J. K. H., Lam, K.-P., Alici, E., Girnita, L., Wagner, A. K., Westerberg, L. S., & Lundqvist, A. (2024). Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease. Journal of Experimental & Clinical Cancer Research, 43(1). https://doi.org/10.1186/s13046-023-02917-5

Bredel, D., Tihic, E., Mouraud, S., Danlos, F.-X., Susini, S., Aglave, M., Alfaro, A., Mohamed-Djalim, C., Rouanne, M., Halse, H., Bigorgne, A., Tselikas, L., Dalle, S., Hartl, D. M., Baudin, E., Guettier, C., Vibert, E., Rosmorduc, O., Robert, C., … Bonvalet, M. (2023). Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers. Journal of Experimental & Clinical Cancer Research, 42(1). https://doi.org/10.1186/s13046-023-02897-6

Ballout, F., Lu, H., Chen, L., Sriramajayam, K., Que, J., Meng, Z., Wang, T. C., Giordano, S., Zaika, A., McDonald, O., Peng, D., & El-Rifai, W. (2022). APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas. Journal of Experimental & Clinical Cancer Research, 41(1). https://doi.org/10.1186/s13046-022-02472-5

Wu, X., Cheng, Y.-S. L., Matthen, M., Yoon, A., Schwartz, G. K., Bala, S., Taylor, A. M., & Momen-Heravi, F. (2021). Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion. Journal of Experimental & Clinical Cancer Research, 40(1). https://doi.org/10.1186/s13046-021-01865-2